The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current ...

Recursion Pharmaceuticals ( RXRX 1.39%) has been a pioneer in using artificial intelligence (AI) to improve the drug ...

As the Q3 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the ...

Shortly after crossing the FDA’s finish line, Ionis Pharmaceuticals’ RNA-targeted hereditary angioedema (HAE) treatment ...

Eli Lilly shares have soared in the triple digits over the past year. Investors are excited about the company’s prospects in the high-growth, weight-loss drug market. Lilly's recently approved ...

Eli Lilly is sounding a warning on proposed tariffs on pharmaceuticals, saying it would raise costs and threaten patient access. The drugmaker said last week that the costs for breakthrough medicines ...

Indianapolis-based Eli Lilly and Co. is acquiring Cambridge, Mass.-based CoLucid Pharmaceuticals for $960 million, the Indianapolis Business Journal reports. Here’s what you should know. 1. Eli Lilly ...

Eli Lilly partners with NVIDIA to build the world’s most powerful AI supercomputer in pharma, accelerating drug discovery and manufacturing innovation.

Eli Lilly and Co.’s stock hit an all-time high and almost reached $1,000 per share on Tuesday in the wake of several ...

Regardless of your investment style, adding a few pharmaceutical stocks to your portfolio is a great idea. These players offer you a certain amount of stability because, no matter what's happening in ...

Eli Lilly (NYSE: LLY) stock has soared 90% over the past year, a huge gain for a pharmaceutical company. These stocks generally are known for steady increases over time instead of big movements over a ...